Literature DB >> 17612048

Role of COX-2 in inflammatory and degenerative brain diseases.

Luisa Minghetti1.   

Abstract

In the last decade, the potential role of cyclooxygenase-2 (COX-2) and prostaglandins (PGs) in brain diseases has been extensively studied. COX-2 over-expression has been associated with neurotoxiticy in acute conditions, such as hypoxia/ischemia and seizures, as well as in inflammatory chronic diseases, including Creutzfeldt-Jakob disease (CJD) and Alzheimer's disease (AD). However, the role played by COX-2 in neurodegenerative diseases is still controversial and further clinical and experimental studies are warranted. In addition, the emerging role of COX-2 in behavioural and cognitive functions strongly indicates that studies aimed at improving our knowledge of the physiological role of COX-2 in the central nervous system are crucial to fully understand the pros and cons of its manipulation in disabling neurological diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17612048     DOI: 10.1007/1-4020-5688-5_5

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  30 in total

1.  Neuronal overexpression of cyclooxygenase-2 does not alter the neuroinflammatory response during brain innate immune activation.

Authors:  Saba Aid; Nishant Parikh; Sara Palumbo; Francesca Bosetti
Journal:  Neurosci Lett       Date:  2010-05-06       Impact factor: 3.046

Review 2.  Targeting cyclooxygenase-2 in depression is not a viable therapeutic approach and may even aggravate the pathophysiology underpinning depression.

Authors:  Michael Maes
Journal:  Metab Brain Dis       Date:  2012-07-07       Impact factor: 3.584

3.  Flavocoxid attenuates gentamicin-induced nephrotoxicity in rats.

Authors:  Dalia H El-Kashef; Asmaa E El-Kenawi; Ghada M Suddek; Hatem A Salem
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-08-15       Impact factor: 3.000

4.  Inflammation after stroke: mechanisms and therapeutic approaches.

Authors:  Muzamil Ahmad; Steven H Graham
Journal:  Transl Stroke Res       Date:  2010-06       Impact factor: 6.829

Review 5.  Cyclooxygenase-2 in synaptic signaling.

Authors:  Hongwei Yang; Chu Chen
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

6.  An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells.

Authors:  Walter J Lukiw; Yuhai Zhao; Jian Guo Cui
Journal:  J Biol Chem       Date:  2008-09-18       Impact factor: 5.157

7.  Neuroprotection in a rabbit model of intraventricular haemorrhage by cyclooxygenase-2, prostanoid receptor-1 or tumour necrosis factor-alpha inhibition.

Authors:  Govindaiah Vinukonda; Anna Csiszar; Furong Hu; Krishna Dummula; Nishi Kant Pandey; Muhammad T Zia; Nicholas R Ferreri; Zoltan Ungvari; Edmund F LaGamma; Praveen Ballabh
Journal:  Brain       Date:  2010-05-20       Impact factor: 13.501

8.  Role of GluN2A NMDA receptor in homocysteine-induced prostaglandin E2 release from neurons.

Authors:  Sathyanarayanan Rajagopal; Ashley Anne Fitzgerald; Satya Narayan Deep; Surojit Paul; Ranjana Poddar
Journal:  J Neurochem       Date:  2019-06-20       Impact factor: 5.372

9.  Neuroprotective Effects of Dexmedetomidine Against Hypoxia-Induced Nervous System Injury are Related to Inhibition of NF-κB/COX-2 Pathways.

Authors:  Wanying Pan; Lin Lin; Nan Zhang; Fuli Yuan; Xiaoxiao Hua; Yueting Wang; Liqiu Mo
Journal:  Cell Mol Neurobiol       Date:  2015-12-18       Impact factor: 5.046

10.  Prolonged opportunity for neuroprotection in experimental stroke with selective blockade of cyclooxygenase-2 activity.

Authors:  Muzamil Ahmad; Yuquin Zhang; Hao Liu; Marie E Rose; Steven H Graham
Journal:  Brain Res       Date:  2009-05-14       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.